Anti-VEGF Conjugate Gets a Win in Retinal Vein Occlusion

(MedPage Today) -- CHICAGO--A novel antibody-biopolymer conjugate (ABC) achieved visual acuity comparable to aflibercept (Eylea) for retinal vein occlusion (RVO) with less frequent dosing, according to a randomized trial reported here.
Best...